Overview
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $2,395,750 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 81 days late). All were audited by a statutory auditor.
- 202503/07/2026
- 202408/07/2025
- 202305/07/2024
- 202211/07/2023
- 202104/10/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Public procurement
703 tenders recorded as contractor: 330 national ($10,345,066) and 373 EU ($85,783,238).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 30, 2026 | Purchase and delivery of dressings and surgical drapes, together with equipment lease (for lots 34 and 35), for the current needs of Uniwersytecki Szpital Kliniczny w Opolu. | $58,495$58,495 | Uniwersytecki Szpital Kliniczny w Opolu | |
| Oct 27, 2026 | Supply of medical devices according to 43 lots | $22,410$22,410 | Szpital Specjalistyczny Im. Ludwika Rydygiera w Krakowie sp. z o.o. | |
| Oct 27, 2026 | Supply of dressings for negative pressure therapy together with the lease of a compatible device. | $11,405$11,405 | Szpital Kliniczny Im. Ks. Anny Mazowieckiej |
Smith & Nephew is the contractor in 268 public sector contracts, worth USD 10.79m in total. They were signed with 101 public buyers. The largest number (10) were signed with Samodzielny Publiczny Zakład Opieki Zdrowotnej w Myślenicach.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 28, 2026 | Purchase – single-use TOPAZ*EZ vaporisation electrodes, 1.06 mm | $2,080 | Wojewódzki Szpital Zespolony w Elblągu | |
| Oct 27, 2026 | for the supply of dressings | $14,344 | Szpital Wojewódzki Im. Prymasa Kardynała Stefana Wyszyńskiego w Sieradzu | |
| Oct 26, 2026 | Single-use medical equipment | $513.24 | Uniwersytecki Szpital Kliniczny w Białymstoku |
Smith & Nephew has been a party to 1 case before the National Appeal Chamber (since 2026). In 1 case it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Jun 23, 2026 | Discontinuance of proceedings | Discontinued | Uniwersytecki Szpital Kliniczny w Poznaniu |
Authorized Representatives
Manner of representation
The company may be represented by each member of the management board acting independently. The company may be represented by two commercial proxies acting jointly or by an independent commercial proxy acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Smith & Nephew Usd Limited | 150,995 | $20,393,706.10 | 99.8611% |
Others | 210 | $28,363.05 | 0.1389% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2005-01-20.
09 1020 1026 0000 1502 0502 0856
88 1880 0009 0000 0011 0238 5000
34 1880 0009 0000 0011 0238 5002
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Servier Polska Servicessp. z o.o. | $125,526,921.78 | servier.pl | ||
| Stada Pharmsp. z o.o. | $98,071,375.86 | walmark.eu | ||
| Olympus Polskasp. z o.o. | $77,594,927.17 | olympus.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| AO East Europesp. z o.o. | $12,156,227.53 | aoeasteurope.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-11-04 | Share capital increase (75,602,000.00 PLN → 75,602,500.00 PLN) | |
| 2019-01-09 | Share capital increase (75,601,500.00 PLN → 75,602,000.00 PLN) | |
| 2018-10-01 | Share capital increase (75,600,500.00 PLN → 75,601,500.00 PLN) | |
| 2018-05-25 | Share capital increase (75,600,000.00 PLN → 75,600,500.00 PLN) | |
| 2018-05-25 | PKD change (Removed: 4 codes; Added: 4 codes) |
FAQ
Last updated: 2026-07-06